Extracellular Vesicle-Associated Proteins in Tissue Repair

Abstract

The administration of (stem) cell-derived extracellular vesicles (EVs) promotes tissue repair through management of different inflammatory, proliferative and remodeling processes in the body. Despite the widely observed biological and therapeutic roles of EVs in wound healing and tissue repair, knowledge on how EVs activate recipient cells and which EV cargo is responsible for the subsequent functional effects is limited. Recent studies hint toward an important role for proteins as functional EV cargo. Here, we provide an overview of how EV-associated proteins promote tissue repair processes and discuss current challenges in evaluating their contribution to EV function and future directions for translating fundamental insights into clinically relevant EV therapies. Extracellular Vesicles: Natural Vehicles of Biological Cargo in Tissue Homeostasis and RepairApart from conventional secretory pathways (see Glossary), cells secrete proteins, nucleic acids, and lipids that are delivered to other cells through vesicles generated via the endosomal pathway or upon direct budding of the plasma membrane. Collectively, these vesicles are called extracellular vesicles (EVs). Despite initial thoughts about being nothing more than the garbage disposal system of cells, it is now well established that these EVs also play important roles in tissue homeostasis through short-and long-distance intercellular communication. EVs isolated from multiple cell types, tissues, and body fluids promote endogenous tissue repair through the modulation of several physiological processes in the body. As a result, EVs bear potential as therapeutics in regenerative medicine, and have been demonstrated to be a functional component of the stem and progenitor cell secretome [1]. Indeed, EVs have been found to promote different reparative processes in the body. Although many studies have set out to identify the functional cargo and cell activation pathways of EVs in tissue repair, the exact mechanisms by which these EVs exert their effects remain elusive. In this review, we describe why proteins expressed on (or in) EVs might be important contributors to EV function, and address the role of specific EV proteins in tissue repair processes in the body. Challenges in the study of individual EV-associated proteins and the implication for the translation of these insights into EV therapeutics will be discussed. EV Biogenesis and Recipient Cell ActivationEVs may be classified based on a set of characteristics including their size, density, process of cellular release, and their protein/lipid composition [2,3]. Three such subgroups are exosomes, microvesicles, and apoptotic bodies (Box 1). Although distinct in biogenesis, it is hard to capture and assign the heterogeneous population of EVs upon isolation toward different classes as they share overlapping physiochemical characteristics and biological markers [4]. To encompass all different vesicle types, the general term EV is increasingly used, as also in this review. EVs are enriched in distinct proteins and...

Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Infection as an Innate Antiviral Mechanism

“…Beyond a signi cant ampli cation of exosomal ACE2 in the anti-SARS-CoV-2 e cacy in comparison to the puri ed rhACE2 proteins or its Fc-fusions 38 , we anticipate that the therapeutic e cacy of ACE2 + exosomes can be further potentiated through co-delivering additional anti-SARS-CoV-2 medicines, such as remdesivir 39,40 . Exosomes have been utilized as drug delivery systems with therapeutic potential against various disorders including infectious diseases and cancers 41,42 . Of note, exosomes derived from both plants and human specimen, such as dendritic cells and tumor cells, have been evaluated in multiple clinical trials and proven safe in human [31][32][33] .…”

Cell-free exosome-laden scaffolds for tissue repair

“…17,18 Exosomes can also activate intracellular signaling pathways to trigger repair of target cells by directly acting at the cell surface without transferring their cargo. 19 Exosomes are also natural nanocarriers. Their phospholipid bilayer structure protects biologically active substances, such as growth factors and miRNA, for sustained release.…”

Exosomes: Emerging Therapy Delivery Tools and Biomarkers for Kidney Diseases

“…Many studies have found that exosomes participate in cancer drug resistance [ 12 ], cutaneous wound healing [ 39 ], liver injury, and so on [ 40 ]. The cargos in EVs have been found to prevent cell death, modulate immune response, maintain vascular integrity, and promote cell activity [ 41 ]. Thus, attempts to recognize the underlying mechanisms of different EVs make it important for us to prevent this progression and seek means of addressing illness.…”